July 29, 2026
As artificial intelligence grows more capable, human skills are becoming more valuable, not less. For decades, the legal profession around the world has rewarded expertise built on deep research, careful analysis and meticulous attention to detail. Today, AI can perform many of those tasks in seconds, summarizing thousands of documents, identifying relevant case law, drafting contracts, analyzing litigation trends and even suggesting legal arguments.
July 29, 2026
Health Canada has been granted a permanent injunction against Canlab Research and its representatives that prevents the company from selling unauthorized injectable peptides in Canada.
July 24, 2026
Gowling WLG has welcomed Guillaume Lavoie Ste-Marie as a partner in its intellectual property litigation and strategy group in Montreal.
July 24, 2026
On July 23, the federal government launched a public consultation “seeking views on how to strengthen transparency for AI systems and AI-generated outputs.”
July 23, 2026
The 21st century has witnessed the emergence of a new form of commons, one that exists not on open pastures, in forests or upon the high seas, but within the vast and interconnected architecture of the digital world. Information, data, online platforms, open source software, digital knowledge repositories and artificial intelligence training materials have collectively given rise to what scholars increasingly describe as the digital commons.
July 17, 2026
The Supreme Court of Canada has reaffirmed that Canadian patent law bars patent claims for “methods of medical treatment” but has also clarified that drug-dosing regimens can be patentable subject matter if they do not seek to monopolize professional medical skill and judgment. In its 158-page judgment handed down July 17, the top court 9-0 dismissed the appeal by generic drug manufacturer Pharmascience Inc. from decisions of the Federal Court and Federal Court of Appeal that affirmed the validity of the patent owned by the respondents, Janssen Inc. and Janssen Pharmaceutica N.V.
July 17, 2026
Appeal by Pharmascience Inc. (Pharmascience) from a judgment of the Federal Court of Appeal which upheld a judgment of the Federal Court. Janssen Inc. and Janssen Pharmaceutica N.V. (together, “Janssen”) filed a patent application in Canada for dosing regimens of an injectable formulation of paliperidone palmitate used to treat schizophrenia and related disorders.
July 10, 2026
Many federally appointed trial judges report stress from excessive workloads, limited control over their time in the workplace and too few support resources, according to a new national survey of judges’ physical and psychological health. On July 9, the Canadian Judicial Council (CJC) reported on extensive research commissioned from the Université de Sherbrooke between 2024 and 2026 by the council of 44 chief and associate chief justices.
July 08, 2026
Mediation doesn’t always end with a handshake. After 39 years of handling commercial and employment disputes, I can tell you that a failed mediation is not necessarily a failure of the process; often, it is useful information. It tells you something about where the parties actually stand, and it forces a decision that matters as much as anything that came before it: arbitration or litigation?
July 08, 2026
A decision of the EU General Court concerns the registrability of a three-dimensional trademark for packaging where the relevant legal issue was whether the shape consisted exclusively of features necessary to obtain a technical result. The General Court is the lower of the two courts that make up the Court of Justice of the European Union.